Operationalizing Substantial Reduction in Functioning Among Young Adults with Chronic Fatigue Syndrome.
Gleason, Kristen D, Stoothoff, Jamie, McClellan, Damani et al. · International journal of behavioral medicine · 2018 · DOI
Quick Summary
This study looked for the best way to measure the 'substantial reduction in functioning' that is required for ME/CFS diagnosis. Researchers used a standard health survey (SF-36) with young adults (ages 18-29) who had ME/CFS and compared them to people without the condition. They found that specific cutoff scores on four areas of the survey—physical functioning, general health, role physical (ability to work), and social functioning—could accurately identify who has ME/CFS.
Why It Matters
ME/CFS diagnosis requires documenting 'substantial reduction in functioning,' but clinicians and researchers lacked consensus on how to measure this objectively. This study provides specific, evidence-based numerical thresholds that could standardize diagnosis and improve consistency across clinical and research settings, potentially reducing diagnostic delays and improving access to care for young adults with ME/CFS.
Observed Findings
Four SF-36 subscales with specific cutoff scores effectively discriminated ME/CFS patients from controls in young adults: Physical Functioning ≤80, General Health ≤47, Role Physical ≤25, and Social Functioning ≤50.
When these four cutoffs were used in combination, they reliably identified patients with ME/CFS versus those without the diagnosis.
The study included 98 young adults with confirmed ME/CFS diagnosis and 272 controls without ME/CFS.
Receiver operating characteristic analysis determined optimal sensitivity and specificity for each subscale cutoff.
Inferred Conclusions
Specific, quantifiable cutoff scores on the SF-36 can operationalize the 'substantial reduction in functioning' criterion required for ME/CFS diagnosis.
A combination of four SF-36 subscales is more effective for diagnosis than any single measure.
These evidence-based thresholds may improve standardization and consistency of ME/CFS diagnosis in both clinical and research settings.
Young adults represent a population for which functional impairment should be assessed using age-appropriate standards.
Remaining Questions
Do these cutoff scores perform equally well in adolescents, middle-aged, and older adults with ME/CFS, or do they require age-adjusted modifications?
What This Study Does Not Prove
This study does not prove these cutoff scores work equally well in adolescents, middle-aged, or older adults with ME/CFS. The cross-sectional design cannot establish whether the SF-36 score changes cause functional impairment or merely reflect it. The findings also do not validate whether these specific thresholds distinguish ME/CFS from other chronic illnesses that also reduce functioning.
How do these SF-36 cutoffs compare to other functional assessment tools or objective measures of activity limitation (e.g., actigraphy, post-exertional malaise documentation)?
Can longitudinal studies confirm whether these cutoff scores predict disease course, treatment response, or long-term outcomes?
How do these thresholds perform in distinguishing ME/CFS from other chronic conditions that similarly reduce physical and social functioning?